208 related articles for article (PubMed ID: 14568897)
1. Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia.
Greinacher A; Lubenow N; Eichler P
Circulation; 2003 Oct; 108(17):2062-5. PubMed ID: 14568897
[TBL] [Abstract][Full Text] [Related]
2. Risk of anaphylaxis after reexposure to intravenous lepirudin in patients with current or past heparin-induced thrombocytopenia.
Cardenas GA; Deitcher SR
Mayo Clin Proc; 2005 Apr; 80(4):491-3. PubMed ID: 15819285
[TBL] [Abstract][Full Text] [Related]
3. Excessive anticoagulation and anaphylactic reaction after rechallenge with lepirudin in a patient with heparin-induced thrombocytopenia.
Badger NO; Butler K; Hallman LC
Pharmacotherapy; 2004 Dec; 24(12):1800-3. PubMed ID: 15585446
[TBL] [Abstract][Full Text] [Related]
4. Severe anaphylactic reaction after repeated intermittent exposure to lepirudin.
Veach SA; Franks AM; Allan MC
Pharmacotherapy; 2007 May; 27(5):760-5. PubMed ID: 17461712
[TBL] [Abstract][Full Text] [Related]
5. Lepirudin: a bivalent direct thrombin inhibitor for anticoagulation therapy.
Greinacher A
Expert Rev Cardiovasc Ther; 2004 May; 2(3):339-57. PubMed ID: 15151481
[TBL] [Abstract][Full Text] [Related]
6. Lepirudin is a safe and effective anticoagulant for patients with heparin-associated antiplatelet antibodies.
Mudaliar JH; Liem TK; Nichols WK; Spadone DP; Silver D
J Vasc Surg; 2001 Jul; 34(1):17-20. PubMed ID: 11436069
[TBL] [Abstract][Full Text] [Related]
7. Lepirudin for heparin-induced thrombocytopenia.
Med Lett Drugs Ther; 1998 Sep; 40(1036):94-5. PubMed ID: 9774965
[No Abstract] [Full Text] [Related]
8. Use of lepirudin in patients with heparin-induced thrombocytopenia and renal failure requiring hemodialysis.
Dager WE; White RH
Ann Pharmacother; 2001; 35(7-8):885-90. PubMed ID: 11485140
[TBL] [Abstract][Full Text] [Related]
9. Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3.
Lubenow N; Eichler P; Lietz T; Greinacher A;
J Thromb Haemost; 2005 Nov; 3(11):2428-36. PubMed ID: 16241940
[TBL] [Abstract][Full Text] [Related]
10. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study.
Greinacher A; Völpel H; Janssens U; Hach-Wunderle V; Kemkes-Matthes B; Eichler P; Mueller-Velten HG; Pötzsch B
Circulation; 1999 Jan 5-12; 99(1):73-80. PubMed ID: 9884382
[TBL] [Abstract][Full Text] [Related]
11. Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass.
Fabrizio MC
J Extra Corpor Technol; 2001 May; 33(2):117-25. PubMed ID: 11467439
[TBL] [Abstract][Full Text] [Related]
12. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators.
Greinacher A; Janssens U; Berg G; Böck M; Kwasny H; Kemkes-Matthes B; Eichler P; Völpel H; Pötzsch B; Luz M
Circulation; 1999 Aug; 100(6):587-93. PubMed ID: 10441094
[TBL] [Abstract][Full Text] [Related]
13. Lepirudin in the management of heparin-induced thrombocytopenia.
Gajra A; Husain J; Smith A
Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1131-41. PubMed ID: 18680447
[TBL] [Abstract][Full Text] [Related]
14. [Lepirudin during cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia].
Boinot C; Lanquetot H; Macchi L; Charrière JM; Menu P
Ann Fr Anesth Reanim; 2003 Jul; 22(7):635-8. PubMed ID: 12946496
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
Dang CH; Durkalski VL; Nappi JM
Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
[TBL] [Abstract][Full Text] [Related]
16. [Lepirudin for therapeutic use in heparin-induced thrombocytopenia].
Harenberg J; Jörg I; Koch S; Fenyvesi T
Hamostaseologie; 2004 May; 24(2):135-43. PubMed ID: 15136878
[TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.
Lancet; 1999 Feb; 353(9151):429-38. PubMed ID: 9989712
[TBL] [Abstract][Full Text] [Related]
18. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation.
Dager WE; Gosselin RC; Yoshikawa R; Owings JT
Ann Pharmacother; 2004 Apr; 38(4):598-601. PubMed ID: 14982973
[TBL] [Abstract][Full Text] [Related]
19. Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance.
Eichler P; Friesen HJ; Lubenow N; Jaeger B; Greinacher A
Blood; 2000 Oct; 96(7):2373-8. PubMed ID: 11001886
[TBL] [Abstract][Full Text] [Related]
20. Hirudin in heparin-induced thrombocytopenia.
Lubenow N; Greinacher A
Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]